Lundbeck

H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research and development, production, marketing, and sale of drugs for the treatment of disorders in the central nervous system (CNS), including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy and insomnia. In 2013, the company's revenue was DKK 15.2 billion (€2.04 billion). Lundbeck is listed on the Copenhagen Stock Exchange (CSE).

Lundbeck

H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research and development, production, marketing, and sale of drugs for the treatment of disorders in the central nervous system (CNS), including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy and insomnia. In 2013, the company's revenue was DKK 15.2 billion (€2.04 billion). Lundbeck is listed on the Copenhagen Stock Exchange (CSE).